SpringWorks Therapeutics Inc. (SWTX) options active on 61K contracts
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- RUM Group signs $13.7 billion GPU services deal, issues warrants
- Funds sell $44bn in semiconductors on AI concerns
- XPeng Inc. (XPEV) Misses Q2 EPS by 100c ; Provides Outlook
Barclays Downgrades Spring Works Therapeutics (SWTX) to Equalweight
April 28, 2025 9:29 AM EDTBarclays analyst Peter Lawson downgraded Spring Works Therapeutics (NASDAQ: SWTX) from Overweight to Equalweight with a price target of $47.00 (from $63.00).
For an analyst ratings summary and ratings history on Spring Works Therapeutics... More
